550.96
price down icon2.82%   -15.97
after-market After Hours: 550.88 -0.08 -0.01%
loading
Idexx Laboratories Inc stock is traded at $550.96, with a volume of 530.33K. It is down -2.82% in the last 24 hours and up +1.90% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$566.93
Open:
$569.14
24h Volume:
530.33K
Relative Volume:
0.81
Market Cap:
$43.41B
Revenue:
$4.45B
Net Income/Loss:
$1.10B
P/E Ratio:
40.54
EPS:
13.591
Net Cash Flow:
$1.06B
1W Performance:
-6.09%
1M Performance:
+1.90%
6M Performance:
-12.46%
1Y Performance:
-15.75%
1-Day Range:
Value
$549.18
$569.14
1-Week Range:
Value
$549.18
$602.00
52-Week Range:
Value
$518.55
$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name
Name
Idexx Laboratories Inc
Name
Phone
(207) 556-0300
Name
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Name
Employee
11,000
Name
Twitter
@idexx
Name
Next Earnings Date
2026-08-04
Name
Latest SEC Filings
Name
IDXX's Discussions on Twitter

Compare IDXX vs TMO, DHR, NTRA, A

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
IDXX icon
IDXX
Idexx Laboratories Inc
550.96 44.95B 4.45B 1.10B 1.06B 13.59
TMO icon
TMO
Thermo Fisher Scientific Inc
588.29 222.96B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
202.45 144.67B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
309.93 45.54B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
148.53 41.87B 7.23B 1.41B 1.09B 4.979

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-15-26 Initiated Citigroup Neutral
Dec-09-25 Initiated Barclays Overweight
Oct-31-25 Upgrade Stifel Hold → Buy
Oct-01-25 Initiated UBS Neutral
Aug-05-25 Reiterated BTIG Research Buy
Jul-01-25 Initiated Jefferies Buy
Dec-02-24 Initiated Leerink Partners Outperform
Jul-25-24 Initiated BTIG Research Buy
Jan-30-24 Downgrade Piper Sandler Overweight → Neutral
Dec-07-23 Initiated Exane BNP Paribas Outperform
Dec-04-23 Upgrade Cleveland Research Neutral → Buy
Aug-02-23 Downgrade Atlantic Equities Overweight → Neutral
Jul-25-22 Downgrade Stifel Buy → Hold
Jul-21-22 Upgrade Goldman Neutral → Buy
Jul-12-22 Initiated Piper Sandler Overweight
May-05-22 Downgrade BofA Securities Buy → Neutral
Feb-08-22 Initiated Atlantic Equities Overweight
Nov-18-21 Initiated Morgan Stanley Overweight
Aug-05-21 Resumed Credit Suisse Outperform
Jul-12-21 Downgrade Guggenheim Buy → Neutral
Feb-17-21 Initiated Barclays Overweight
Sep-09-19 Initiated Goldman Neutral
May-23-19 Initiated Guggenheim Buy
Nov-02-18 Reiterated BofA/Merrill Buy
May-07-18 Reiterated Stifel Buy
Jan-16-18 Initiated Piper Jaffray Overweight
Aug-23-17 Upgrade BofA/Merrill Neutral → Buy
Jul-28-17 Upgrade CL King Neutral → Buy
Feb-03-17 Downgrade Feltl & Co. Hold → Sell
Sep-29-16 Resumed BofA/Merrill Neutral
Aug-16-16 Reiterated Stifel Buy
Aug-03-16 Upgrade Northcoast Sell → Neutral
Jul-20-16 Reiterated Canaccord Genuity Buy
Apr-19-16 Reiterated Canaccord Genuity Buy
Apr-01-16 Initiated CL King Neutral
Mar-21-16 Reiterated Stifel Buy
Feb-04-16 Initiated Credit Suisse Outperform
Oct-29-15 Reiterated Stifel Buy
Aug-28-15 Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15 Reiterated Stifel Buy
Jul-23-15 Reiterated Canaccord Genuity Buy
View All

Idexx Laboratories Inc Stock (IDXX) Latest News

pulisher
02:03 AM

IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - Yahoo Finance

02:03 AM
pulisher
Aug 13, 2026

Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore

Aug 13, 2026
pulisher
Aug 12, 2026

IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance

Aug 12, 2026
pulisher
Aug 12, 2026

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Aug 12, 2026
pulisher
Aug 12, 2026

IDXX|IDEXX Laboratories Inc|Price:569.852|Chg%:-0.728 - TradingKey

Aug 12, 2026
pulisher
Aug 11, 2026

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Aug 11, 2026
pulisher
Aug 11, 2026

IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Eagle-Tribune

Aug 11, 2026
pulisher
Aug 11, 2026

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating - marketscreener.com

Aug 11, 2026
pulisher
Aug 10, 2026

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 10, 2026
pulisher
Aug 10, 2026

NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 10, 2026
pulisher
Aug 09, 2026

Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories Inc Stock Historical Valuations | HAM:IX1 - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories Inc Stock Baskets - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories Inc (HAM:IX1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories (HAM:IX1) Other Operating Expense : €0 Mil (TTM As of Jun. 2026) - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories (HAM:IX1) Marketable Securities : €0 Mil (As of Jun. 2026) - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories Inc (HAM:IX1) Competitors 2026 - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

IDEXX Laboratories Inc (HAM:IX1) Stock News, Headlines & Updates - GuruFocus

Aug 09, 2026
pulisher
Aug 09, 2026

Who's Buying or Selling IDEXX Laboratories Inc (HAM:IX1) Stock Today? - GuruFocus

Aug 09, 2026
pulisher
Aug 08, 2026

IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aug 08, 2026
pulisher
Aug 08, 2026

IDEXX Labs posts 9% organic growth, raises EPS forecast, driven by global diagnostic expansion. - Pluang

Aug 08, 2026
pulisher
Aug 08, 2026

IDEXX Laboratories: Worth The Premium (NASDAQ:IDXX) - Seeking Alpha

Aug 08, 2026
pulisher
Aug 08, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by Beacon Investment Advisory Services Inc. - MarketBeat

Aug 08, 2026
pulisher
Aug 08, 2026

Assenagon Asset Management S.A. Boosts Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 08, 2026
pulisher
Aug 08, 2026

Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

Janus Henderson Group PLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Clinical Visits Keep Falling. IDEXX Laboratories’ Q2 Earnings Report Say That Doesn’t Matter. - TIKR.com

Aug 06, 2026
pulisher
Aug 06, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by Empowered Funds LLC - MarketBeat

Aug 06, 2026
pulisher
Aug 05, 2026

IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

IDEXX Labs Is Maintained at Neutral by UBS - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

IDEXX Labs Is Maintained at Neutral by Citigroup - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792 - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

IDEXX Laboratories Inc (HAM:IX1) Stock Earnings Transcripts - GuruFocus

Aug 05, 2026
pulisher
Aug 05, 2026

IDEXX (IDXX) Stock Rewards Margin Strength And Recurring Diagnostics Growth - Sahm

Aug 05, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories Inc (IDXX) Stock Up 3.6% and Still Undervalued -- GF Score: 96/100 - GuruFocus

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights - GuruFocus

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories 2026: Revenue $1.22B, EPS $4.27— 10-Q Summary - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories (NASDAQ: IDXX) lifts Q2 2026 profit and cash flow - Stock Titan

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories, Inc. Stock 12‑Month Price Target Raised to $719, Implies 27% Upside - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

Idexx Laboratories, Inc. Updates Earnings Guidance for 2026 - marketscreener.com

Aug 04, 2026
pulisher
Aug 04, 2026

IDEXX Laboratories jumps 5% on strong results, raised guidance (IDXX:NASDAQ) - Seeking Alpha

Aug 04, 2026

Idexx Laboratories Inc Stock (IDXX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$309.93
price down icon 0.27%
A A
$148.53
price down icon 0.51%
WAT WAT
$412.17
price down icon 0.32%
IQV IQV
$236.66
price down icon 2.01%
$190.89
price down icon 0.91%
Cap:     |  Volume (24h):